Pharmacokinetics, pharmacodynamics and drug interaction potential of enfuvirtide.
about
An albumin-conjugated peptide exhibits potent anti-HIV activity and long in vivo half-lifeBiophysical property and broad anti-HIV activity of albuvirtide, a 3-maleimimidopropionic acid-modified peptide fusion inhibitor.GLUE that sticks to HIV: a helix-grafted GLUE protein that selectively binds the HIV gp41 N-terminal helical region.Clinically relevant drug-drug interactions between antiretrovirals and antifungalsDrug-drug interactions and tolerance in combining antituberculosis and antiretroviral therapy.Enfuvirtide cerebrospinal fluid (CSF) pharmacokinetics and potential use in defining CSF HIV-1 originAntiviral drug disposition and natural health products: risk of therapeutic alteration and resistance.Pediatric Dosing and Body Size in Biotherapeutics.Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: focus on drug-drug interactions with rifamycins.Helix-Grafted Pleckstrin Homology Domains Suppress HIV-1 Infection of CD4-Positive Cells.Evaluation of pharmacokinetic interactions between long-acting HIV-1 fusion inhibitor albuvirtide and lopinavir/ritonavir, in HIV-infected subjects, combined with clinical study and simulation results.Precision medicine for HIV: where are we?Pharmacokinetic and Chemical Synthesis Optimization of a Potent d-Peptide HIV Entry Inhibitor Suitable for Extended-Release Delivery.
P2860
Q33559066-FA4568F6-9232-487E-94C3-4EAEABC103A6Q34189558-16771D48-9A29-48EA-93D6-9394DF7DB3B2Q35751518-FB9CE74C-0FC7-407F-B47D-A20A1E0244A6Q35892563-F0651039-2D77-4B3E-97AC-3CD692B498ECQ36235489-C2BEA920-9E94-4CAD-A4E7-B20BE41239B4Q37235279-ADD933CD-3E98-468E-8385-F91413B83103Q37481442-A105D547-ED6A-41B0-A7EC-8FF47E18D8B1Q37666711-F0D57958-B272-4DC9-8823-E1FB3B74B3DFQ38207924-2F22A28F-C81E-4CD9-B2BB-67139E92DCC9Q40500571-D0A05032-FE6F-4910-A0C5-CBBDB77CEA75Q40725569-DE21F685-C611-4D86-ADE6-59F43DA40191Q47569821-1C44E5E1-994F-46EA-8E5C-3B8937C5C28FQ50046992-E7C10230-BFFF-4C9F-B04F-079EDF2BF42E
P2860
Pharmacokinetics, pharmacodynamics and drug interaction potential of enfuvirtide.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Pharmacokinetics, pharmacodynamics and drug interaction potential of enfuvirtide.
@ast
Pharmacokinetics, pharmacodynamics and drug interaction potential of enfuvirtide.
@en
Pharmacokinetics, pharmacodynamics and drug interaction potential of enfuvirtide.
@nl
type
label
Pharmacokinetics, pharmacodynamics and drug interaction potential of enfuvirtide.
@ast
Pharmacokinetics, pharmacodynamics and drug interaction potential of enfuvirtide.
@en
Pharmacokinetics, pharmacodynamics and drug interaction potential of enfuvirtide.
@nl
prefLabel
Pharmacokinetics, pharmacodynamics and drug interaction potential of enfuvirtide.
@ast
Pharmacokinetics, pharmacodynamics and drug interaction potential of enfuvirtide.
@en
Pharmacokinetics, pharmacodynamics and drug interaction potential of enfuvirtide.
@nl
P2093
P1476
Pharmacokinetics, pharmacodynamics and drug interaction potential of enfuvirtide.
@en
P2093
Indravadan H Patel
Keith Nieforth
Miklos Salgo
Xiaoping Zhang
P304
P356
10.2165/00003088-200544020-00003
P577
2005-01-01T00:00:00Z
P6179
1041005138